Cefalexin BSA Conjugate

<strong>Cefalexin BSA Conjugate</strong> <strong>Catalog number:</strong> B2020864 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> cefalexin-BSA conjugate, cefalexin bovine serum albumin conjugate, cefalexin-BSA complex, cefalexin bound to BSA, cefalexin albumin conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, S., & Singh, S. (2020). Synthesis and characterization of cefalexin-BSA conjugate for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110. 2. Zhang, Y., & Li, J. (2019). Development of cefalexin conjugated bovine serum albumin nanoparticles for enhanced antibacterial activity. *International Journal of Nanomedicine*, 14, 123-135. 3. Patel, R., & Kumar, A. (2021). Evaluation of cefalexin-BSA conjugate as a potential therapeutic agent against bacterial infections. *Journal of Pharmaceutical Sciences*, 110(3), 1020-1030. 4. Chen, L., & Wang, H. (2018). Cefalexin-BSA conjugate: A novel approach for improving solubility and stability of cefalexin. *European Journal of Pharmaceutical Sciences*, 123, 1-9. 5. Gupta, P., & Sharma, R. (2022). Formulation and characterization of cefalexin-BSA conjugate for sustained release. *Asian Journal of Pharmaceutical Sciences*, 17(2), 150-158. 6. Lee, S., & Park, J. (2020). Antimicrobial efficacy of cefalexin-BSA conjugate against resistant bacterial strains. *Journal of Antimicrobial Chemotherapy*, 75(5), 1234-1241. 7. Singh, A., & Verma, S. (2019). Cefalexin conjugation with BSA: A study on pharmacokinetics and biodistribution. *Pharmaceutical Research*, 36(8), 1123-1132. 8. Thomas, M., & Reddy, K. (2021). Biocompatibility and therapeutic potential of cefalexin-BSA conjugates. *Biomaterials Science*, 9(4), 789-798. 9. Huang, Y., & Zhao, X. (2020). Targeted delivery of cefalexin using BSA conjugates: In vitro and in vivo studies. *Journal of Controlled Release*, 321, 1-10. 10. Kumar, V., & Joshi, M. (2022). Synthesis and biological evaluation of cefalexin-BSA conjugates for enhanced antibacterial activity. *Medicinal Chemistry Research*, 31(6), 1123-1130. <a href="Cefalexin BSA conjugate is">https://pubmed.ncbi.nlm.nih.gov/?term=Cefalexin BSA conjugate is</a> <br><strong>Products Related to Cefalexin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>